0001461859-20-000029.txt : 20201125 0001461859-20-000029.hdr.sgml : 20201125 20201125152004 ACCESSION NUMBER: 0001461859-20-000029 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201125 DATE AS OF CHANGE: 20201125 EFFECTIVENESS DATE: 20201125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVENTRIX INC CENTRAL INDEX KEY: 0001283259 IRS NUMBER: 200372415 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-357195 FILM NUMBER: 201350041 BUSINESS ADDRESS: STREET 1: 12647 ALCOSTA BLVD. STREET 2: SUITE 400 CITY: SAN RAMON STATE: CA ZIP: 94583 BUSINESS PHONE: 925-830-1000 MAIL ADDRESS: STREET 1: 12647 ALCOSTA BLVD. STREET 2: SUITE 400 CITY: SAN RAMON STATE: CA ZIP: 94583 FORMER COMPANY: FORMER CONFORMED NAME: CHF TECHNOLOGIES INC DATE OF NAME CHANGE: 20040310 D/A 1 primary_doc.xml X0708 D/A LIVE 0001283259 BIOVENTRIX INC 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 925-830-1000 DELAWARE CHF TECHNOLOGIES INC Corporation true KENNETH MILLER 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Executive Officer Director MICHAEL TAGLICH 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director STEPHEN HEALY 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director GEORGE FAZIO 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director MARK RAVICH 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director WILLIAM ABBOTT 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Executive Officer RAYMOND COHEN 12647 ALCOSTA BLVD. SUITE 400 SAN RAMON CA CALIFORNIA 94583 Director Other Decline to Disclose 06b true 0001461859-20-000003 2020-01-02 true true true CONVERTIBLE NOTES false 0 TAGLICH BROTHERS, INC. 29102 None None 790 NEW YORK AVENUE SUITE 209 HUNTINGTON NY NEW YORK 11743 All States false 25000000 14755700 10244300 false 108 1000000 true 0 PLACEMENT AGENT ALSO TO RECEIVE WARRANTS TO PURCHASE COMMON STOCK. 500000 true false BIOVENTRIX INC /s/William R. Abbott William R. Abbott Chief Financial Officer 2020-11-25